Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) is reporting second quarter net income of $340.2 million, compared to a net loss of $717.3 million during the same period last year. The company also reported second quarter net sales of $2 billion, an increase of 65.3% over the prior year period.

“Our performance in the second quarter improved meaningfully from the first quarter 2021 across all regions and product categories as recovery from the global pandemic continued to take hold. While we anticipate some ongoing COVID-19 pressure, we expect continued improvement in procedure volume recovery through the second half of 2021,” said Bryan Hanson, president and chief executive officer of Zimmer Biomet. “Against this backdrop, Zimmer Biomet has continued to execute, investing in our business, expanding our portfolio and developing and launching innovative products designed to improve mobility and health. This execution enables ZB to build and deliver value for our customers and shareholders and to move our mission forward for the patients we ultimately serve.”

You can connect to the full earnings report by clicking here.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}